Legal Representation
Attorney
Robert Kelly
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 2, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 1, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 29, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2013 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 29, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 31, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 30, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 4, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 4, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 15, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 30, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 30, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 13, 2012 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 13, 2012 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 13, 2012 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 13, 2012 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 13, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 9, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 5, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Nutritional supplements for therapeutic nutrition and nutritional supplementation made in significant part of curcumin; Pharmaceutical preparations for use in formulating curcuminoid nanofractions for anti-inflammatory therapy, treatment of pain, treatment of swelling, treatment of inflammation, treatment of autoimmune diseases and syndromes, treatment of dementia, treatment of fibromyalgia, antimicrobial therapy, antifungal therapy, antibacterial therapy, and antiviral therapy
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005